Estimating lung cancer and cardiovascular mortality in female breast cancer patients receiving radiotherapy

Thomas Mulliez; Kurt Barbé; Mark de Ridder

doi:10.1016/j.radonc.2020.03.022

Estimating lung cancer and cardiovascular mortality in female breast cancer patients receiving radiotherapy

Thomas Mulliez, Kurt Barbé, Mark de Ridder

Research output: Contribution to journal › Article

1 Citation (Scopus)

Abstract

By integrating data of the PLCO cancer screening trial, SCORE-risk charts and radiotherapy excess ratios, we were able to create risk charts estimating radiotherapy-induced lung cancer and cardiovascular mortality in female breast cancer patients. These risk models might be useful to individualize radiotherapy and optimize lung cancer and cardiovascular prevention and screening.

Original language	English
Pages (from-to)	111-116
Number of pages	6
Journal	Radiotherapy and Oncology
Volume	152
Early online date	2020
DOIs	https://doi.org/10.1016/j.radonc.2020.03.022
Publication status	Published - Nov 2020

Bibliographical note

Keywords

Breast cancer
Lung cancer induction
cardiovascular mortality
Radiotherapy

Access to Document

10.1016/j.radonc.2020.03.022

Link to publication in Scopus

Fingerprint Dive into the research topics of 'Estimating lung cancer and cardiovascular mortality in female breast cancer patients receiving radiotherapy'. Together they form a unique fingerprint.

Cite this

@article{138decb8f6964e21914ea1d286786174,

title = "Estimating lung cancer and cardiovascular mortality in female breast cancer patients receiving radiotherapy",

abstract = "By integrating data of the PLCO cancer screening trial, SCORE-risk charts and radiotherapy excess ratios, we were able to create risk charts estimating radiotherapy-induced lung cancer and cardiovascular mortality in female breast cancer patients. These risk models might be useful to individualize radiotherapy and optimize lung cancer and cardiovascular prevention and screening.",

keywords = "Breast cancer, Lung cancer induction, cardiovascular mortality, Radiotherapy",

author = "Thomas Mulliez and Kurt Barb{\'e} and {de Ridder}, Mark",

year = "2020",

month = "11",

doi = "10.1016/j.radonc.2020.03.022",

language = "English",

volume = "152",

pages = "111--116",

journal = "Radiotherapy and Oncology",

issn = "0167-8140",

publisher = "Elsevier Ireland Ltd",

}

TY - JOUR

T1 - Estimating lung cancer and cardiovascular mortality in female breast cancer patients receiving radiotherapy

AU - Mulliez, Thomas

AU - Barbé, Kurt

AU - de Ridder, Mark

PY - 2020/11

Y1 - 2020/11

N2 - By integrating data of the PLCO cancer screening trial, SCORE-risk charts and radiotherapy excess ratios, we were able to create risk charts estimating radiotherapy-induced lung cancer and cardiovascular mortality in female breast cancer patients. These risk models might be useful to individualize radiotherapy and optimize lung cancer and cardiovascular prevention and screening.

AB - By integrating data of the PLCO cancer screening trial, SCORE-risk charts and radiotherapy excess ratios, we were able to create risk charts estimating radiotherapy-induced lung cancer and cardiovascular mortality in female breast cancer patients. These risk models might be useful to individualize radiotherapy and optimize lung cancer and cardiovascular prevention and screening.

KW - Breast cancer

KW - Lung cancer induction

KW - cardiovascular mortality

KW - Radiotherapy

UR - http://www.scopus.com/inward/record.url?scp=85087026812&partnerID=8YFLogxK

U2 - 10.1016/j.radonc.2020.03.022

DO - 10.1016/j.radonc.2020.03.022

M3 - Article

C2 - 32600774

VL - 152

SP - 111

EP - 116

JO - Radiotherapy and Oncology

JF - Radiotherapy and Oncology

SN - 0167-8140

ER -